VerdictStats

Securities and Exchange Commission

SEC v. Sumit Rai

PendingFiled: January 14, 2026

Sumit Rai allegedly made misrepresentations to investors and misappropriated at least $10.6 million in investor funds, according to the SEC. Kim deMora was charged with aiding and abetting the alleged fraud. Relief Defendant Cancer Check is alleged to have received ill-gotten gains in connection with the fraudulent scheme.

Summary generated from official Securities and Exchange Commission press release

Source: Securities and Exchange Commission Press Release ↗

Parties

Defendants / Respondents
  • Sumit Rai
  • SVN Med LLC
  • NVS Med Inc.
  • Onco Filtration, Inc.
  • Kim deMora
  • Cancer Check Labs, LLC

Dates

Filed
January 14, 2026
Published
January 15, 2026

Case Details

Industry
Finance